Robert Trondl

2.1k total citations · 1 hit paper
15 papers, 1.5k citations indexed

About

Robert Trondl is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Robert Trondl has authored 15 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Organic Chemistry and 5 papers in Molecular Biology. Recurrent topics in Robert Trondl's work include Metal complexes synthesis and properties (8 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Robert Trondl is often cited by papers focused on Metal complexes synthesis and properties (8 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Robert Trondl collaborates with scholars based in Austria, Hungary and New Zealand. Robert Trondl's co-authors include Bernhard K. Keppler, Michael A. Jakupec, Christian R. Kowol, Walter Berger, Petra Heffeter, Vladimir B. Arion, Éva A. Enyedy, Tamás Kiss, Christian G. Hartinger and Irene Lichtscheidl and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and Inorganic Chemistry.

In The Last Decade

Robert Trondl

15 papers receiving 1.5k citations

Hit Papers

NKP-1339, the first ruthenium-based anticancer drug on th... 2014 2026 2018 2022 2014 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Trondl Austria 14 1.1k 876 334 296 192 15 1.5k
Orsolya Dömötör Hungary 23 930 0.8× 635 0.7× 424 1.3× 283 1.0× 282 1.5× 56 1.3k
Ke-Bin Huang China 23 727 0.7× 667 0.8× 364 1.1× 225 0.8× 211 1.1× 47 1.5k
C. Marzano Italy 16 742 0.7× 933 1.1× 436 1.3× 203 0.7× 132 0.7× 29 1.4k
Lara Massai Italy 26 1.0k 0.9× 847 1.0× 625 1.9× 156 0.5× 296 1.5× 88 1.9k
Mauro Coluccia Italy 26 1.7k 1.5× 1.3k 1.5× 646 1.9× 187 0.6× 258 1.3× 52 2.2k
Piedad del Socorro Murdoch United Kingdom 22 1.3k 1.2× 1.0k 1.2× 677 2.0× 246 0.8× 297 1.5× 33 1.9k
Maram T. Basha Saudi Arabia 15 655 0.6× 629 0.7× 181 0.5× 194 0.7× 151 0.8× 48 1.1k
Isabel Gracia‐Mora Mexico 21 955 0.9× 607 0.7× 403 1.2× 368 1.2× 195 1.0× 57 1.5k
C. Scolaro Switzerland 10 1.7k 1.5× 1.6k 1.9× 371 1.1× 358 1.2× 299 1.6× 10 2.1k
Teresa Gianferrara Italy 20 792 0.7× 752 0.9× 439 1.3× 234 0.8× 481 2.5× 44 1.5k

Countries citing papers authored by Robert Trondl

Since Specialization
Citations

This map shows the geographic impact of Robert Trondl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Trondl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Trondl more than expected).

Fields of papers citing papers by Robert Trondl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Trondl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Trondl. The network helps show where Robert Trondl may publish in the future.

Co-authorship network of co-authors of Robert Trondl

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Trondl. A scholar is included among the top collaborators of Robert Trondl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Trondl. Robert Trondl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Austin, Shane, Barbara Scheiber‐Mojdehkar, Walter Berger, et al.. (2015). Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagy. Oncotarget. 7(2). 1242–1261. 25 indexed citations
3.
Klapproth, Erik, Christine Unger, Irene Lichtscheidl, et al.. (2015). Three-dimensional and co-culture models for preclinical evaluation of metal-based anticancer drugs. Investigational New Drugs. 33(4). 835–847. 43 indexed citations
4.
Trondl, Robert, Christian R. Kowol, Petra Heffeter, et al.. (2014). Triapine and a More Potent Dimethyl Derivative Induce Endoplasmic Reticulum Stress in Cancer Cells. Molecular Pharmacology. 85(3). 451–459. 35 indexed citations
5.
Trondl, Robert, Petra Heffeter, Christian R. Kowol, et al.. (2014). ChemInform Abstract: NKP‐1339, the First Ruthenium‐Based Anticancer Drug on the Edge to Clinical Application. ChemInform. 45(36). 1 indexed citations
6.
Trondl, Robert, Petra Heffeter, Christian R. Kowol, et al.. (2014). NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application. Chemical Science. 5(8). 2925–2932. 583 indexed citations breakdown →
7.
Bacher, Felix, Éva A. Enyedy, Nóra V. Nagy, et al.. (2013). Copper(II) Complexes with Highly Water-Soluble l- and d-Proline–Thiosemicarbazone Conjugates as Potential Inhibitors of Topoisomerase IIα. Inorganic Chemistry. 52(15). 8895–8908. 60 indexed citations
8.
Kurzwernhart, Andrea, Wolfgang Kandioller, Caroline Bartel, et al.. (2012). Targeting the DNA-topoisomerase complex in a double-strike approach with a topoisomerase inhibiting moiety and covalent DNA binder. Chemical Communications. 48(40). 4839–4839. 123 indexed citations
9.
Enyedy, Éva A., Orsolya Dömötör, Erika Varga, et al.. (2012). Comparative solution equilibrium studies of anticancer gallium(III) complexes of 8-hydroxyquinoline and hydroxy(thio)pyrone ligands. Journal of Inorganic Biochemistry. 117. 189–197. 62 indexed citations
10.
Enyedy, Éva A., Nóra V. Nagy, Tamás Kiss, et al.. (2012). l- and d-Proline Thiosemicarbazone Conjugates: Coordination Behavior in Solution and the Effect of Copper(II) Coordination on Their Antiproliferative Activity. Inorganic Chemistry. 51(17). 9309–9321. 65 indexed citations
11.
Trondl, Robert, Petra Heffeter, Michael A. Jakupec, Walter Berger, & Bernhard K. Keppler. (2012). NKP-1339, a first-in-class anticancer drug showing mild side effects and activity in patients suffering from advanced refractory cancer. BMC Pharmacology and Toxicology. 13(S1). 15 indexed citations
12.
Kowol, Christian R., Petra Heffeter, Walter Miklos, et al.. (2011). Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compounds. JBIC Journal of Biological Inorganic Chemistry. 17(3). 409–423. 126 indexed citations
13.
Kowol, Christian R., Robert Trondl, Vladimir B. Arion, et al.. (2009). Fluorescence properties and cellular distribution of the investigational anticancer drugTriapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) and its zinc(ii) complex. Dalton Transactions. 39(3). 704–706. 78 indexed citations
14.
Kowol, Christian R., Robert Trondl, Petra Heffeter, et al.. (2009). Impact of Metal Coordination on Cytotoxicity of 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone (Triapine) and Novel Insights into Terminal Dimethylation. Journal of Medicinal Chemistry. 52(16). 5032–5043. 145 indexed citations
15.
Rasche, Frank, et al.. (2006). Chilling and cultivar type affect the diversity of bacterial endophytes colonizing sweet pepper (Capsicum anuumL.). Canadian Journal of Microbiology. 52(11). 1036–1045. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026